Hollencrest Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $139K | Hold |
|
|||||
|
2025
Q2 | $140K | Hold |
|
|||||
|
2025
Q1 | $108K | Buy |
|
|||||
|
2024
Q4 | $27.5K | Hold |
|
|||||
|
2024
Q3 | $23.1K | Hold |
|
|||||
|
2024
Q2 | $24.4K | Hold |
|
|||||
|
2024
Q1 | $27.7K | Hold |
|
|||||
|
2023
Q4 | $47K | Hold |
|
|||||
|
2023
Q3 | $31.3K | Hold |
|
|||||
|
2023
Q2 | $35.9K | Hold |
|
|||||
|
2023
Q1 | $28.2K | Hold |
|
|||||
|
2022
Q4 | $23.9K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $241K | Hold |
|
|||||
|
2017
Q3 | $301K | Hold |
|
|||||
|
2017
Q2 | $222K | Sell |
|
|||||
|
2017
Q1 | $309K | Sell |
|
|||||
|
2016
Q4 | $277K | Sell |
|
|||||
|
2016
Q3 | $305K | Sell |
|
|||||
|
2016
Q2 | $409K | Buy |
|
|||||
|
2016
Q1 | $337K | Sell |
|
|||||
|
2015
Q4 | $501K | Buy |
|
|||||
|
2015
Q3 | $432K | Buy |
|
|||||
|
2015
Q2 | $538K | Sell |
|
|||||
|
2015
Q1 | $425K | Hold |
|
|||||
|
2014
Q4 | $414K | Sell |
|
|||||
|
2014
Q3 | $767K | Sell |
|
|||||
|
2014
Q2 | $1.13M | Sell |
|
|||||
|
2014
Q1 | $1.39M | Hold |
|
|||||
|
2013
Q4 | $1.42M | Buy |
|